These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18276584)

  • 1. Beta-arrestin-mediated signaling regulates protein synthesis.
    DeWire SM; Kim J; Whalen EJ; Ahn S; Chen M; Lefkowitz RJ
    J Biol Chem; 2008 Apr; 283(16):10611-20. PubMed ID: 18276584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
    Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
    J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
    Wei H; Ahn S; Barnes WG; Lefkowitz RJ
    J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.
    Coffa S; Breitman M; Hanson SM; Callaway K; Kook S; Dalby KN; Gurevich VV
    PLoS One; 2011; 6(12):e28723. PubMed ID: 22174878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.
    Kumar P; Lau CS; Mathur M; Wang P; DeFea KA
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C346-57. PubMed ID: 17442737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
    Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
    J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells.
    Quoyer J; Longuet C; Broca C; Linck N; Costes S; Varin E; Bockaert J; Bertrand G; Dalle S
    J Biol Chem; 2010 Jan; 285(3):1989-2002. PubMed ID: 19915011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
    Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
    J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
    Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
    Huet E; Boulay F; Barral S; Rabiet MJ
    Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells.
    Broca C; Quoyer J; Costes S; Linck N; Varrault A; Deffayet PM; Bockaert J; Dalle S; Bertrand G
    J Biol Chem; 2009 Feb; 284(7):4332-42. PubMed ID: 19074139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation.
    Oligny-Longpré G; Corbani M; Zhou J; Hogue M; Guillon G; Bouvier M
    Proc Natl Acad Sci U S A; 2012 Apr; 109(17):E1028-37. PubMed ID: 22493236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.
    Lee MH; El-Shewy HM; Luttrell DK; Luttrell LM
    J Biol Chem; 2008 Jan; 283(4):2088-97. PubMed ID: 18006496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner.
    Szereszewski JM; Pampillo M; Ahow MR; Offermanns S; Bhattacharya M; Babwah AV
    PLoS One; 2010 Sep; 5(9):e12964. PubMed ID: 20886089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.
    Ahn S; Shenoy SK; Wei H; Lefkowitz RJ
    J Biol Chem; 2004 Aug; 279(34):35518-25. PubMed ID: 15205453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
    Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.
    Wei H; Ahn S; Shenoy SK; Karnik SS; Hunyady L; Luttrell LM; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10782-7. PubMed ID: 12949261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for engagement of β-arrestin2 by the transactivated EGFR in agonist-specific regulation of δ receptor activation of ERK1/2.
    Zhang LS; Wang YJ; Ju YY; Zan GY; Xu C; Hong MH; Wang YH; Chi ZQ; Liu JG
    Br J Pharmacol; 2015 Oct; 172(20):4847-63. PubMed ID: 26211551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.